Thus, while MMP-9 is considered as a classic dry eye marker and clinical tests are commercially available, its usefulness as a biomarker after refractive surgery is difficult to evaluate due to a wide variability in levels in some patients. The gene discussed is MMP9; the disease is Keratoconjunctivitis sicca.